Objective:
To examine the association between restless leg syndrome (RLS) and the development of Parkinson disease (PD), and to evaluate the role of dopaminergic pathways.
Approach:
- Study Design: A nationwide retrospective cohort study using data from the Korean National Health Insurance Service Sample Cohort from 2002 to 2019.
- Participants: 9,919 patients with RLS matched with 9,919 controls by age, sex, income, region, and comorbidity profile.
- Analysis: Inverse probability of treatment weighting with stabilized propensity score weights was applied to adjust for demographic, clinical, and lifestyle factors.
Key Findings:
- Patients with RLS had a higher incidence of PD (10.1 per 10,000 patient-years) compared to controls (6.3 per 10,000 patient-years).
- Among RLS patients, those treated with dopamine agonists (DAs) had a lower incidence of PD (0.5%) compared to those not treated (2%).
- During follow-up, 158 patients with RLS developed PD compared with 99 patients in the control group.
Interpretation:
The findings suggest that RLS may be a risk factor for PD rather than an early manifestation, with potential mechanisms involving nondopaminergic pathways.
Limitations:
- Diagnostic accuracy may vary due to potential misclassification of rapid eye movement sleep behavior disorder as RLS.
- Differentiating idiopathic RLS from secondary RLS based solely on DA treatment may be challenging.
Conclusion:
The study indicates a complex relationship between RLS and PD.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
